• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响口服脊髓灰质炎疫苗免疫原性的因素:在巴西和冈比亚的前瞻性评估。世界卫生组织口服脊髓灰质炎疫苗协作研究小组

Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine.

出版信息

J Infect Dis. 1995 May;171(5):1097-106. doi: 10.1093/infdis/171.5.1097.

DOI:10.1093/infdis/171.5.1097
PMID:7751683
Abstract

To assess factors that may influence the immunogenicity of oral poliovirus vaccine (OPV), neutralizing antibody responses were measured in 1409 infants in Brazil and the Gambia who were randomized to receive one of four different formulations of OPV at approximately birth and at 6, 10, and 14 weeks. Overall seroconversion rates at the end of the trial were 85% for poliovirus type 1 (P1), 94% for type 2 (P2), and 68% for type 3 (P3). Factors associated with vaccine failure included high levels of maternal antibody (P1, P2, and P3), vaccination during the rainy season (P1, P2, and P3), diarrhea at the time of vaccination (P2 and P3), household exposure to other OPV recipients (P1), and breast-feeding (P3) (P < .05 for each factor, logistic regression analysis). OPV containing twice the standard potency of Sabin type 1 virus increased seroconversion rates to P1 by 8% in Brazil (P < .05) and 15% in the Gambia (P < .001). Suboptimal responses to OPV in developing countries are determined by a complex array of factors related to the vaccine, host, and environment.

摘要

为评估可能影响口服脊髓灰质炎疫苗(OPV)免疫原性的因素,对巴西和冈比亚的1409名婴儿进行了中和抗体反应检测,这些婴儿在出生时以及6周、10周和14周时被随机分配接受四种不同配方OPV中的一种。试验结束时,1型脊髓灰质炎病毒(P1)的总体血清转化率为85%,2型(P2)为94%,3型(P3)为68%。与疫苗接种失败相关的因素包括高水平的母源抗体(P1、P2和P3)、雨季接种疫苗(P1、P2和P3)、接种时腹泻(P2和P3)、家庭中接触其他OPV接种者(P1)以及母乳喂养(P3)(各因素P<0.05,逻辑回归分析)。含有两倍标准效力Sabin 1型病毒的OPV在巴西使P1的血清转化率提高了8%(P<0.05),在冈比亚提高了15%(P<0.001)。发展中国家对OPV的反应欠佳是由一系列与疫苗、宿主和环境相关的复杂因素决定的。

相似文献

1
Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine.影响口服脊髓灰质炎疫苗免疫原性的因素:在巴西和冈比亚的前瞻性评估。世界卫生组织口服脊髓灰质炎疫苗协作研究小组
J Infect Dis. 1995 May;171(5):1097-106. doi: 10.1093/infdis/171.5.1097.
2
Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.婴儿口服脊髓灰质炎疫苗与灭活脊髓灰质炎疫苗联合免疫:冈比亚、阿曼和泰国的一项随机试验结果。世界卫生组织口服和灭活脊髓灰质炎疫苗协作研究组
J Infect Dis. 1997 Feb;175 Suppl 1:S215-27. doi: 10.1093/infdis/175.supplement_1.s215.
3
The effect of diarrhea on oral poliovirus vaccine failure in Brazil.腹泻对巴西口服脊髓灰质炎疫苗失效的影响。
J Infect Dis. 1997 Feb;175 Suppl 1:S258-63. doi: 10.1093/infdis/175.supplement_1.s258.
4
Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.在大规模疫苗接种运动与常规免疫规划中口服脊髓灰质炎疫苗的免疫原性。
Bull World Health Organ. 1995;73(6):769-77.
5
Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains.母传抗体对婴儿对来自萨宾株的脊髓灰质炎灭活疫苗的免疫应答的影响。
Hum Vaccin Immunother. 2019;15(5):1160-1166. doi: 10.1080/21645515.2019.1572410. Epub 2019 Mar 19.
6
Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.婴儿口服脊髓灰质炎疫苗与灭活脊髓灰质炎疫苗联合免疫:在冈比亚、阿曼和泰国开展的一项随机试验结果。世界卫生组织口服和灭活脊髓灰质炎疫苗协作研究组
Bull World Health Organ. 1996;74(3):253-68.
7
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.在智利婴儿中单独使用或与二价口服脊髓灰质炎疫苗序贯使用灭活脊髓灰质炎病毒疫苗:一项随机、对照、开放性标签、四期、非劣效性研究。
Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26.
8
Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.口服补充碘不会降低对口服脊髓灰质炎疫苗的中和抗体反应。
Bull World Health Organ. 1999;77(6):484-91.
9
Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.口服五价人-牛重配轮状病毒疫苗与口服脊髓灰质炎病毒疫苗的联合使用。
Pediatr Infect Dis J. 2008 Oct;27(10):874-80. doi: 10.1097/INF.0b013e3181782780.
10
Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial.锌补充剂未能提高口服脊髓灰质炎疫苗的免疫原性:一项随机对照试验。
Vaccine. 2015 Feb 4;33(6):819-25. doi: 10.1016/j.vaccine.2014.12.001. Epub 2014 Dec 11.

引用本文的文献

1
Non-mucosal vaccination strategies to enhance mucosal immunity.增强黏膜免疫力的非黏膜疫苗接种策略。
Vaccine Insights. 2023 Jul;2(6):229-236. doi: 10.18609/vac.2023.034. Epub 2023 Jul 12.
2
Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants.婴儿体内的母传抗体对婴儿接种灭活脊灰疫苗的免疫原性和安全性的影响。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2050106. doi: 10.1080/21645515.2022.2050106. Epub 2022 Apr 8.
3
Poliovirus immunity among adults in the Democratic Republic of the Congo: a cross-sectional serosurvey.
刚果民主共和国成年人中的脊髓灰质炎免疫:横断面血清学调查。
BMC Infect Dis. 2022 Jan 5;22(1):30. doi: 10.1186/s12879-021-06951-6.
4
Seasonal modulation of antibody response to diphtheria-tetanus-pertussis vaccination in infants: a cohort study in rural Gambia.婴儿对白喉-破伤风-百日咳疫苗的抗体反应的季节性调节:冈比亚农村的一项队列研究。
BMC Public Health. 2021 Jul 22;21(1):1442. doi: 10.1186/s12889-021-11383-7.
5
Mucosal immunity to poliovirus.肠道黏膜对脊髓灰质炎病毒的免疫。
Mucosal Immunol. 2022 Jan;15(1):1-9. doi: 10.1038/s41385-021-00428-0. Epub 2021 Jul 8.
6
Drivers of Infectious Disease Seasonality: Potential Implications for COVID-19.传染病季节性的驱动因素:对 COVID-19 的潜在影响。
J Biol Rhythms. 2021 Feb;36(1):35-54. doi: 10.1177/0748730420987322. Epub 2021 Jan 24.
7
Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine.肠道微生物群对脊髓灰质炎疫苗黏膜IgA抗体反应的影响。
NPJ Vaccines. 2020 Jun 9;5(1):47. doi: 10.1038/s41541-020-0194-5. eCollection 2020.
8
Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.口服脊髓灰质炎疫苗在 MAL-ED 出生队列研究中的反应:对脊髓灰质炎根除策略的考虑。
Vaccine. 2019 Jan 7;37(2):352-365. doi: 10.1016/j.vaccine.2018.05.080. Epub 2018 Nov 12.
9
Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.母体抗体对婴儿接种二价口服脊髓灰质炎疫苗后灭活脊髓灰质炎疫苗免疫原性的影响:对消灭脊髓灰质炎终局的启示。
Clin Infect Dis. 2018 Oct 30;67(suppl_1):S57-S65. doi: 10.1093/cid/ciy649.
10
Exploring the relationship between environmental enteric dysfunction and oral vaccine responses.探讨环境肠道功能障碍与口服疫苗反应之间的关系。
Future Microbiol. 2018 Jul;13(9):1055-1070. doi: 10.2217/fmb-2018-0016. Epub 2018 Jun 21.